AI in CGM: Glucose forecasting, predictive analytics & beyond

In this special World Diabetes Day episode, host Dr Phyllisa Deroze is joined by Dr Noël Barengo and diabetes advocate Nkiruka Okoro to explore why early action matters across the diabetes spectrum. Through powerful personal experiences and expert insights, they discuss the importance of recognising the signs of type 1 diabetes before a life-threatening crisis, understanding individual risk of type 2 diabetes, and turning early detection into meaningful prevention and care. Hosted on Acast. See acast.com/privacy for more information.

In this episode of D-Talk, Dr Phyllisa Deroze speaks with Professor Jonathan Shaw, Chair of the IDF World Diabetes Congress 2027 Programme Committee, about the science and global health issues shaping the Congress in Singapore. They discuss AI, bioengineering and precision therapeutics, the future of GLP-1-based therapies, diabetes care in humanitarian crises and gaps in women’s health. Hosted on Acast. See acast.com/privacy for more information.

How is AI transforming continuous glucose monitoring – and what could it mean for people living with diabetes? In the second episode of our four-part Technology & AI podcast series, Host Dr Phyllisa Deroze is joined by Professor Julia Mader and Dr Manoj Chawla to explore glucose forecasting, predictive analytics and more personalised care. They also tackle the big questions around trust, transparency, access and clinical oversight as AI becomes increasingly embedded in diabetes technology. Hosted on Acast. See acast.com/privacy for more information.

How can a local conversation become a catalyst for lasting change? In this episode of D-Talk, host Dr Phyllisa Deroze speaks with Tanzanian diabetes advocate Lucy Johnbosco Kifaru, founder of Diabetes Consciousness for Community (Di-Co-Co). Lucy discusses working with schools, journalists, community leaders and families to challenge stigma and improve diabetes understanding, while Phyllisa reflects on using storytelling, music and lived experience in her advocacy and awareness activities. Together, they explore how listening, cultural respect and partnerships can create lasting community-led action. Hosted on Acast. See acast.com/privacy for more information.

In this episode, we explore how technology and artificial intelligence are beginning to reshape diabetes care, from earlier detection of complications to more personalised support for people living with diabetes. Host Dr Phyllisa Deroze is joined by Dr Amit Dey and Dr Elaine Chow to discuss the promise of AI, but also the responsibility that comes with it: ensuring tools are safe, transparent, equitable, and designed around real individual needs. They highlight why people living with diabetes must be involved in shaping these technologies, and why stronger governance, better data systems, and inclusive design will be essential as AI moves from innovation to real-world impact. Tune in for a thoughtful conversation on the future of AI in diabetes management, and what it will take to make that future trustworthy, accessible, and truly human-centred.  Hosted on Acast. See acast.com/privacy for more information.

This episode of D-Talk continues the conversation on diabetic macular oedema (DME), a diabetes-related eye condition that can threaten vision but is often preventable with early detection and treatment. Host Dr Phyllisa Deroze is joined by Dr Matthew Cunningham, a vitreoretinal specialist and advocate for the “All Eyes on DME” campaign, who brings expert clinical and research insights on this topic. We take a deeper dive into what DME is, who is at risk, and how it can be managed to protect long-term eye health. Talking about vision loss can feel daunting - and that’s exactly why these conversations matter.  Hosted on Acast. See acast.com/privacy for more information.

Diabetes-related eye disease can be difficult to talk about, especially when it involves the risk of vision loss. In this episode of D-Talk, we explore how humour can help break down fear and open important conversations around diabetic macular oedema (DME), a leading cause of vision loss in people living with diabetes. Host Dr Phyllisa Deroze is joined by Damon Wayans – comedian, actor and advocate for the “All Eyes on DME” campaign – who shares how laughter, honesty, and lived experience can raise awareness, encourage action, and help people feel less alone when facing serious health challenges. Hosted on Acast. See acast.com/privacy for more information.

CGM is transforming diabetes care, but what if access, not innovation, is the real barrier? This episode highlights a pilot project in Egypt reimagining CGM access as a comprehensive care system. Host Dr Phyllisa Deroze welcomes Dr Andrew Behnke to discuss how the initiative combines technology, education and local expertise to improve outcomes for children with type 1 diabetes. Rather than just distributing sensors, the project trains families and healthcare teams to interpret and act on CGM data in real time. Hosted on Acast. See acast.com/privacy for more information.

In Episode 4 of the second season of Doing Well with Diabetes, a special podcast series in partnership with Diabetics Doing Things, host Rob Howe speaks with Kerry Murphy about navigating type 1 diabetes (T1D) as a parent and turning fear into action. From supporting multiple family members with T1D to founding Follow T1Ds, Kerry shares how her lived experience led her to advocate for safer, more equitable care in schools. She explores the gap between modern diabetes technology and outdated school practices, and how parents can move from overwhelm to strategic advocacy. A powerful conversation about protecting children and driving systems change. Hosted on Acast. See acast.com/privacy for more information.

In this episode, host Dr Phylissa Deroze is joined by Dr Michael Haller, Chief of Pediatric Endocrinology at the University of Florida, and diabetes advocate Ricardo de Oliveira to explore type 1 diabetes screening as both a medical breakthrough and a political issue. They share how early detection can prevent life-threatening diagnosis experiences, reduce complications, and reshape care. The conversation addresses policy gaps, health equity and why screening must become a standard, accessible part of diabetes care worldwide. Hosted on Acast. See acast.com/privacy for more information.